DaVita HealthCare Partners (DVA) saw its stock price soar by 5.05% during intraday trading on Thursday, indicating strong positive momentum.
The significant price movement appears to be driven by analyst action, as Truist Securities raised its price target on DaVita to $158 from $128, while maintaining a Hold rating. This represents a substantial increase in the firm's valuation outlook for the company.
According to analyst polls by FactSet, DaVita has an average rating of Hold with a mean price target of $151, providing additional context to the market's reaction to Truist's updated assessment.